<code id='0852A27D46'></code><style id='0852A27D46'></style>

<acronym id='0852A27D46'></acronym>

<center id='0852A27D46'><center id='0852A27D46'><tfoot id='0852A27D46'></tfoot></center><abbr id='0852A27D46'><dir id='0852A27D46'><tfoot id='0852A27D46'></tfoot><noframes id='0852A27D46'>

<optgroup id='0852A27D46'><strike id='0852A27D46'><sup id='0852A27D46'></sup></strike><code id='0852A27D46'></code></optgroup>

<b id='0852A27D46'><label id='0852A27D46'><select id='0852A27D46'><dt id='0852A27D46'><span id='0852A27D46'></span></dt></select></label></b><u id='0852A27D46'></u>

~~<i id='0852A27D46'><strike id='0852A27D46'><tt id='0852A27D46'><pre id='0852A27D46'></pre></tt></strike></i>~~

Home» focus» explore

explore

explore

author：entertainment 2025-09-29 12:21:58 Page View：75

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Living with Fabry disease, a condition that causes chronic pain
Next article： Novavax promises a turnaround & Lilly roils the obesity market

Wikipedia

Virginia high school admissions case could be legal follow

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Iowa House, Senate pass 6

Iowa House, Senate pass 6

0:22IowaGov.KimReynoldstakespartinapaneldiscussionduringaRepublicanGovernorsAssociationconferenceonN

After affirmative action ruling, medical educators look to 'holistic review'

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Head of FDA's diagnostics center, who led through Covid, retires

TimothyStenzelledtheFDA'sdiagnosticsdivisionduringtheCovid-19pandemic,astheagencyscrambledtopushthro

read more